Artificial Intelligence
Global Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Regional Outlook and Forecast, 2021 – 2027
New York, May 05, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Regional Outlook and Forecast, 2021 – 2027” – https://www.reportlinker.com/p06273386/?utm_source=GNW
These modern digital technologies have enabled the delivery of patient-centric care to patients who are located remotely, minimizing the requirement for emergency department visits and drastically lowering hospitalization expenses, hence accelerating market growth. Telehealth applications aim to improve access to fundamental healthcare services while also improving their quality and safety.
Telecare services assist in the monitoring of elderly people’s health. Remote monitoring centers’ digital software and platforms can monitor and help the elderly for abnormal behavior patterns or any warning indicators of falls, further increasing utilization. Moreover, the increasing geriatric population around the world is expected to fuel the telecare industry in the upcoming years. According to the World Health Organization, one in every six individuals in the world will be over 60 years old by 2030. Additionally, some telecare technologies monitor the elderly person’s environment and level of consciousness, automatically triggering the appropriate response. As a result, technical advances like these helps to foster market growth.
The majority of potential patients, as well as many current patients, establish their first and recurrent relationships through the website of a telehealth services provider. The website is a powerful reputation booster as well as a pillar of the brand. It also provides answers to queries, alleviates fears, and establishes a connection. This factor is majorly encouraging market players across the world to bring more advancement across their businesses in order to increase their customer engagement.
Certain service providers have already begun to benefit from the new climate conditions. The main obstacle is to identify how to leverage telehealth services and technology. A fresh approach to healthcare marketing is now required. This factor would offer a significant opportunity for various new market players to enter the market.
COVID-19 Impact
The outbreak of the COVID-19 caused a severe harm to various economies all over the world. The pandemic considerably demolished various businesses, irrespective of their sizes, across the world. In addition, due to the rapid spread of the infection, governments all over the world were forced to impose nationwide lockdowns in their countries. While various industries were significantly devastated, the healthcare sectors across the world were constantly booming. Due to government-imposed restrictions, and reduced in-person consultations and hospital visits, virtual care services and telehealth applications observed an increased demand and popularity as a measure to reduce physical contact between patients and practitioners in healthcare facilities and reduce the risk of infection.
Market Growth Factors
Increasing government support and initiatives
Telehealth has proven to be effective in reducing distance barriers and providing healthcare delivery in rural areas. A significant number of populations, particularly in developing countries, reside in rural areas where they do not have access to adequate healthcare. As a result, several governments are now emphasizing on providing healthcare services in remote areas via virtual care platforms. Additionally, numerous governments support the employment of electronic intensive care units (e-ICUs), which allow for remote patient monitoring via high-speed internet, two-way cameras, and electronic devices. The industry is growing due to strong government support and the establishment of favorable legislation to stimulate the use of telehealth solutions.
Increasing geriatric population all over the world
As per the data shared by the National Institute of Health, there is a total of 617 million people aged 65 and over across the world. In addition, this population is accounting for about 8.5 percent of the overall population of the world. Moreover, this number is estimated to increase in the future. The increasing number of geriatric populations is majorly attributed to the rising utilization of telecare services and solutions. At the age of 65 and above, people suffer from numerous disadvantages. For example, people in old age usually face issues such as immobility and problems in walking. Moreover, in disabilities like paralysis, these people significantly require solutions like telecare.
Market Restraining Factors
Technical barriers in the utilization of Telecare services
A major stumbling block in the deployment of telecare services is the occurrence of various potential technological barriers. Despite the considerable potential of telecare services, technological teleconsultation, and infrastructure obstacles are major stumbling blocks to the growth of the market in underdeveloped countries prevailing across the world. The adoption of digital health platforms necessitates the utilization of cutting-edge communications devices, high-speed internet with enough of bandwidth, along with increased storage capacity to incorporate and transmit medical data, all of which are still in short supply in many developing nations. High installation costs for necessary systems, devices, and equipment related to real-time monitoring of healthcare parameters are a major market stumbling block.
Product Type Outlook
Based on Product Type, the market is segmented into Activity Monitoring and Remote Medication. In 2020, the activity monitoring segment acquired the largest revenue share of the telecare market. The increasing growth of this segment is attributed to the rising disposable income of people across the world. Moreover, activity monitoring comprises sensor-based tools that allow the user to monitor their physical activities and indication at their home. These factors are contributing to the growth of the telecare market.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2020, Europe registered the largest revenue share of the telecare market. The market across this region is flourishing due to improvements in the sector of telecare and continual research activities performed by many market participants. The adoption of telecare solutions is being aided by improving internet access and increased smartphone prevalence. The rising demand for healthcare support in the regions’ rural and remote areas is prompting key players to find creative solutions to meet the demand.
The major strategies followed by the market participants are Partnership. Based on the Analysis presented in the Cardinal matrix; Apple, Inc. and Google LLC are the forerunners in the Telecare Market. Companies such as Samsung Electronics Co., Ltd., Sanofi S.A., AllScripts Healthcare Solutions, Inc. are some of the key innovators in the Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, AllScripts Healthcare Solutions, Inc., AT&T, Inc., Samsung Electronics Co., Ltd., Apple, Inc., Qualcomm, Inc., and Google LLC.
Strategies Deployed in Telecare Market
Partnerships, Collaborations and Agreements:
Dec-2021: Samsung, along with AT&T teamed up with Qure4u. This collaboration aimed to deliver remote patient monitoring for high blood pressure patients. Under this collaboration, Qure4u chose FirstNet, developed by AT&T, to provide highly secure and reliable connectivity to support RPM kits to help vulnerable patients in underserved and rural areas.
Oct-2021: AT&T joined hands with Navigil, a designer, manufacturer, and provider of mobile personal safety technology and services. This collaboration aimed to introduce its artificial intelligence-powered product, which consists of equipped Navigil 580 sensor on the dashboard, mobile, and wristwatches. Moreover, Wristwatch displays automated alarms, location information with emergency messaging. Additionally, it utilizes AT&T’s nationwide LTE-M cellular network designed to support the Internet of Things with a long battery, small form factors, and low cost.
Aug-2021: Apple Health app teamed up with BlueJeans Telehealth, which helps replicate the experience of onsite encounters. This collaboration focused on providing patients data such as sleep, fall, and heart rate with doctors during the clinical telemedicine visit.
Nov-2020: Google cloud came into partnership with Claritas HealthTech to unveiled tRAD, a teleradiology product. Through this partnership, tRAD provides a single platform for patients, that access online to review clinical reports, radiology images, and consult with physicians.
Sep-2020: Apple came into a partnership with the US Department of Veterans Affairs to expand access to telehealth services. This partnership aimed to enhance the platform of Apple’s expertise to provide the best telehealth experience to health professionals and Veterans.
Aug-2020: Google formed a multi-year, partnership with Amwell, a telehealth company that brings healthcare into the homes and workplaces of patients. Under this partnership, the companies aimed to expand their access to improve patient and clinician experiences, virtual care. Although, it influences their unique capabilities to transform and deliver new medical solutions around the continuum of care.
Mar-2020: AT&T teamed up with VitalTech, a rapidly growing market leader in Virtual Care, Telehealth, and Remote Patient Monitoring. Through this collaboration, the companies aimed to deliver health care services to the patient when they require them the most. Additionally, it would provide data analytic and highly secured connectivity whereas companies’ ability would bring a dependable end-to-end Virtual care solution to the market. Also, VitalCare provides 60 days free telehealth service platform to support patients and physicians.
Product Launches and Product Expansions:
Mar-2021: Abbott received FDA approval for NeuroSphere Virtual Clinic, a first-of-its-kind technology. This technology would enable patients to interact with physicians, ensure proper surroundings and functionality, and get new treatment settings remotely as per their requirements. Moreover, this technology is capable to provide optimal treatment for chronic pain and movement disorder patients, who don’t have proper health care facilities, are unable to go to the doctor due to covid, and have difficulty accessing care.
Sep-2020: Sanofi introduced a digital WeHealth ecosystem to connect doctors and patients. The product provides consumers to consult an easy buy and receive of the prescription from a medical professional of their choice. Moreover, it also delivers all the healthcare and medical needs to their doorsteps.
Jan-2020: HARMAN, a subsidiary of Samsung Electronics introduced HARMAN RCP, A remote monitoring solution. The product offers access to health data by connecting a wide group of non-medical and medical devices. Additionally, it would further provide digitalized services and processes to keep up with the demands and market pace.
Acquisitions and Mergers:
May-2018: Allscripts took over HealthGrid, a leading mobile, enterprise patient engagement solution. Through this acquisition, Allscripts expanded FollowMyHealth platforms, focusing on connecting consumers with providers. Moreover, it would combine the FollowMyHealth platform along with HealthGrid capabilities, providing enterprises to reach 100% of their patients without signing into a portal.
Jan-2018: Allscripts took over EHR vendor Practice Fusion, expanding its solution offering towards ambulatory clinics and small physician practices. Through this acquisition, the company aimed to propel innovation in improving clinical outcomes, real-world evidence research, addressing gaps in care, and improving clinical outcomes.
Scope of the Study
Market Segments covered in the Report:
By Product Type
• Activity Monitoring
• Remote Medication Management
By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
• Abbott Laboratories
• Pfizer, Inc.
• Sanofi S.A.
• Johnson & Johnson
• AllScripts Healthcare Solutions, Inc.
• AT&T, Inc.
• Samsung Electronics Co., Ltd.
• Apple, Inc.
• Qualcomm, Inc.
• Google LLC
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p06273386/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Uncategorized7 days agoIntegrity Food Marketing Joins Forces with CA Ferolie to Expand East Coast Reach from Maine to Florida
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
-
Uncategorized7 days ago
DFI’s Latest Compact Industrial Computer Equipped with AI Acceleration Module
-
Uncategorized7 days ago
DFI Amplifies AI Capability for the Thriving EV Market and Beyond
-
Artificial Intelligence4 days agoSilent Eight secures AIA as its latest client
